According to a newly published market research report by 24LifeSciences, global Bruton's Tyrosine Kinase (BTK) inhibitors market was valued at USD 6,941 million in 2024 and is projected to reach USD 9,622 million by 2031, growing at a compound annual growth rate (CAGR) of 4.9% during the forecast period. BTK inhibitors are small molecule therapeutics that selectively inhibit the Bruton's...

The Mammalian Polyclonal IGG Antibody Market is witnessing steady growth due to increasing applications in diagnostics, therapeutics, and research. Polyclonal IgG antibodies, derived from mammalian sources such as rabbits, goats, and sheep, are widely used due to their ability to recognize multiple epitopes on a single antigen. This characteristic enhances sensitivity and makes them highly...

The global healthcare industry is experiencing a significant transformation as neurological disorders continue to rise at an alarming rate. Conditions such as Alzheimer’s disease and other forms of dementia are placing increasing pressure on healthcare systems worldwide. Rising Disease Burden and Treatment DemandThe growing prevalence of dementia across aging populations has intensified...

Biotechnology companies and research institutions are increasingly adopting algal-based expression systems for the production of recombinant proteins, vaccines, enzymes, antibodies, and therapeutic compounds. Algal Protein Expression Systems Market Size and Growth Analysis The Algal Protein Expression Systems Market size is expected to reach US$ 523.52 Million by 2034 from US$...

According to a newly published market research report by 24LifeSciences, global cGMP Process Development market was valued at USD 3.75 billion in 2025 and is projected to reach USD 6.06 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025–2032. cGMP process development represents the critical discipline of systematically designing,...

The global chemotherapy market continues to play a critical role in cancer treatment, forming a cornerstone of oncology care worldwide. Despite the emergence of advanced therapies such as immunotherapy and targeted treatments, chemotherapy remains widely used due to its effectiveness across multiple cancer types. The increasing global burden of cancer, coupled with advancements in drug...

According to a newly published market research report by 24LifeSciences, global Endotoxin Detection Kit market was valued at USD 720 million in 2024 and is projected to reach USD 1.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period 2025–2032. Endotoxin detection kits are specialized diagnostic tools used to detect and quantify...

According to a newly published market research report by 24LifeSciences, global PD-1 and PD-L1 monoclonal antibody market was valued at USD 32.6 billion in 2025 and is projected to reach USD 63.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.7% during the forecast period 2026–2034. PD-1/PD-L1 monoclonal antibodies represent a groundbreaking class of...

The Global Upstream Bioprocessing Market is witnessing rapid expansion, driven by the growing demand for biologics, vaccines, and cell-based therapies. Upstream bioprocessing involves the initial stages of biopharmaceutical production, including cell culture development, media preparation, and bioreactor operations. These processes are essential for producing high-quality biological products...

The humanized mice model market is gaining significant momentum as pharmaceutical companies, biotechnology firms, and research institutions increasingly rely on advanced preclinical models to improve drug development and disease research. Humanized mice are genetically engineered or biologically modified mice that carry human cells, tissues, or genes, enabling researchers to study human...